Genetics and pathophysiology of neonatal diabetes mellitus

por Naylor, Rochelle N, Greeley, Siri Atma W, Bell, Graeme I, Philipson, Louis H
Publicado 2011

Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis

por Letourneau, Lisa R., Carmody, David, Wroblewski, Kristen, Denson, Anna M., Sanyoura, May, Naylor, Rochelle N., Philipson, Louis H., Greeley, Siri Atma W.
Publicado 2017

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

por Naylor, Rochelle N., John, Priya M., Winn, Aaron N., Carmody, David, Greeley, Siri Atma W., Philipson, Louis H., Bell, Graeme I., Huang, Elbert S.
Publicado 2014

Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT)

por Tosur, Mustafa, Gandolfo, Laura, Balasubramanyam, Ashok, Naylor, Rochelle N., Pollin, Toni I., Rasouli, Neda, Cromer, Sara J., Buse, John B., Redondo, Maria J.
Publicado 2023

Systematic Review of Treatment of Beta-Cell Monogenic Diabetes

por Naylor, Rochelle N., Patel, Kashyap A., Kettunen, Jarno L.T., Männistö, Jonna M.E., Støy, Julie, Beltrand, Jacques, Polak, Michel, Vilsbøll, Tina, Greeley, Siri A.W., Hattersley, Andrew T., Tuomi, Tiinamaija
Publicado 2023

Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry

por Bowden, Tiana L., Letourneau-Freiberg, Lisa R., Kandasamy, Balamurugan, Sanyoura, May, Tian, Persephone, Harris, Anastasia G., Bell, Graeme I., Philipson, Louis H., Naylor, Rochelle N., Greeley, Siri Atma W.
Publicado 2021

Role of Noninsulin Therapies Alone or in Combination in Chromosome 6q24-Related Transient Neonatal Diabetes: Sulfonylurea Improves but Does Not Always Normalize Insulin Secretion

por Carmody, David, Beca, Flavius A., Bell, Charles D., Hwang, Jessica L., Dickens, Jazzmyne T., Devine, Nancy A., Mackay, Deborah J.G., Temple, I. Karen, Hays, Lisa R., Naylor, Rochelle N., Philipson, Louis H., Greeley, Siri Atma W.
Publicado 2015

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)

por Gregory, Justin M., Smith, T. Jordan, Slaughter, James C., Mason, Holly R., Hughey, Curtis C., Smith, Marta S., Kandasamy, Balamurugan, Greeley, Siri Atma W., Philipson, Louis H., Naylor, Rochelle N., Letourneau, Lisa R., Abumrad, Naji N., Cherrington, Alan D., Moore, Daniel J.
Publicado 2019